Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly oral R126638 in disto-lateral toenail onychomycosis (Phase IIa)
2005-004611-30Phase 2Completed
- Sponsor
- Barrier Therapeutics, Inc.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pramiconazole in onychomycosis, sponsored by Barrier Therapeutics, Inc. Primary endpoint: Therapeutic cure at week 12. Started Dec 2005; status: completed.
02
Drugs
pramiconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2005-004611-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004611-30.